NCT06271980View on ClinicalTrials.gov

Early-Onset Colorectal Cancer Recurrence

CompletedOBSERVATIONAL
Enrollment

177

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Colorectal Cancer RecurrentColorectal CancerColorectal NeoplasmsColorectal AdenocarcinomaColorectal Cancer Stage IColorectal Cancer Stage IIColorectal Cancer Stage III
Interventions
OTHER

ENCORE

A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

IRCCS San Raffaele

OTHER

collaborator

Institute of Biomedical Research of Salamanca, Salamanca, Spain

UNKNOWN

lead

City of Hope Medical Center

OTHER